Bi

Biodrugs

BioDrugs is a hybrid journal covering the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease, serving R&D professionals and clinicians interested in biologic therapies.

Looking to publish in Biodrugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Oncology, Pharmacology & Pharmacy
Impact Factor 6.9
Quartile Q1
Open Access Type Hybrid
ISSN 1173-8804
eISSN 1179-190X
Invitation Only No
Cost Range Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Biodrugs accepts the following article types. Click on an article type to view submission instructions.

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract must be unstructured.
Manuscript Review Articles must be up to 8000 words. The manuscript must include Key Points beneath the abstract, a Declarations section, documentation of any large language model use in the Methods section or another suitable section, and a statement identifying who conceived the article, performed the literature search and data analysis, and drafted or critically revised the work.
References There is no limit on the number of references. Citations must use numbered references in square brackets. The reference list must include only cited published or accepted works, be numbered consecutively, include full DOI links when available, and use standard journal title abbreviations or the full journal title if unsure.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and large figures should be uploaded separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to Biodrugs using Livewrite Premium

Systematic Review

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract may be up to 450 words if needed for full compliance with relevant reporting guidelines. Abstract should be structured.
Manuscript Manuscript must not exceed 10,000 words. A disclosure statement is required, use of a large language model must be documented in the Methods section or a suitable alternative part of the manuscript, and the manuscript must include a section entitled 'Declarations' with required statements and declarations.
References There is no limit on the number of references. Citations must use numbered references in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to Biodrugs using Livewrite Premium

Original Research

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract must be structured.
Manuscript Original Research articles must not exceed 6000 words. Original Research articles must include a data availability statement explaining how to access supporting data, include a disclosure statement, document any large language model use in the Methods section or a suitable alternative, and include declarations under a 'Statements and Declarations' or 'Declarations' heading.
References There is no limit on the number of references. Citations must use numbered references in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links included when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals and cited in consecutive numerical order, each table must have a caption, and each figure must have a concise caption included in the manuscript text file rather than in the figure file.
Reformat to Biodrugs using Livewrite Premium

Narrative Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract must be unstructured.
Manuscript Review Articles must not exceed 8000 words. The manuscript must include a Declarations section before the reference list, two to three Key Points beneath the abstract, documentation of any large language model use in the Methods section or another suitable section, and a statement identifying who had the idea for the article, who performed the literature search and data analysis, and who drafted and or critically revised the work.
References There is no limit on the number of references. References must be cited in the text using numbers in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links included when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures uploaded separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by captions, with figure captions included in the manuscript text file rather than in the figure files.
Reformat to Biodrugs using Livewrite Premium

Meta-Analysis

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract should be structured.
Manuscript The manuscript must include a Declarations section, two to three Key Points beneath the abstract, documentation of any large language model use in the Methods section or suitable alternative, and a disclosure statement.
References There is no limit on the number of references. References must use numbered citations in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to Biodrugs using Livewrite Premium

Summary Of Research Articles (Sras)

Cover Letter Cover Letter requirements are not specified.
Abstract Summary Of Research Articles must include a brief abstract stating that the article is a summary of the source article, and they must not include a Plain Language Summary abstract. Text-based Summary Of Research Articles must not exceed 1000 words including the abstract, while graphic-based versions should include a brief abstract of ideally no more than 200 words.
Manuscript Summary Of Research Articles must be a maximum of 4 PDF pages, and text-based versions must not exceed 1000 words including the abstract. The title must begin with “Summary of Research:” followed by the source article title, and the first sentence in the main text must state that the article is a summary of the source article and cite that article. Text-only Summary Of Research Articles must include Key Summary Points below the abstract with a maximum of 4–5 single-sentence bullets, must include standard article information including Acknowledgements, Author information and Ethics declarations, must include a Conflict of Interest section stating “Please see original article for full author disclosures.”, must declare any funding or editorial assistance, and must document any large language model use in the manuscript.
References The source publication must be the only reference in a Summary Of Research Article. References must be cited in the text using numbers in square brackets. The reference list must contain only the source publication and its entries must be numbered consecutively.
Figures & Tables Graphic-based Summary Of Research Articles must be submitted as a single figure, while text-based versions should include figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Graphic-based Summary Of Research Articles should be submitted as a PDF and the graphic must include the SRA title, author names, a shortened reference to the source article, the Adis logo, the Peer Reviewed stamp, maximum dimensions of 17.2 cm by 46.4 cm, and text no smaller than 10 pt.
Reformat to Biodrugs using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must be 150 to 250 words.
Manuscript Letters To The Editor must not exceed 1000 words. Manuscripts must include a Declarations section before the reference list, provide two to three Key Points bullet points beneath the abstract, document any large language model use in the Methods section or another suitable section if no Methods section is available, and include statements under non-applicable Declarations headings as 'Not applicable'.
References There is no limit on the number of references. References must be cited in the text using numbers in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication, with full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and large figures should be submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to Biodrugs using Livewrite Premium

Recent Publications

Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen–Directed CAR T-Cell Therapy

Maria T. Kuipers, Jorne Migchelbrink, Anne Marijn Kramer, Mathilde C. M. Kouwenhoven, Sonja Zweegman, Kaz Groen, Niels W. C. J. van de Donk

10.1007/s40259-026-00784-y
View Publication

Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders

Justin Zhong, Ruijiang Song, Nacim Kerrouche, Xinyu Yu, Yotam Levin, Adam Mor

10.1007/s40259-026-00785-x
View Publication

Recombinant Protein Drugs: A 2025 Update

Hèctor López-Laguna, Eloi Parladé, Marianna T. P. Favaro, Carlos Palacín, Eric Voltà-Durán, Neus Ferrer-Miralles, José Luis Corchero, Rosalía Rodríguez-Rodríguez, Esther Vázquez, Ugutz Unzueta, Antonio Villaverde

10.1007/s40259-026-00783-z
View Publication

Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials

Zhihua Ran, Yan Chen, Yinglei Miao, Yufang Wang, Xiang Gao, Jie Zhong, Xueli Ding, Chengdang Wang, Xiaolan Zhang, Yijuan Ding, Naizhong Hu, Dan Tang, Jiao Yu, Chenxi Qian, Jun Shen

10.1007/s40259-026-00776-y
View Publication

Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France

Allison Singier, Stéphane Vignot, David Desplas, Mahmoud Zureik, Nadia Haddy

10.1007/s40259-026-00778-w
View Publication

Frequently asked questions

How long does it take to publish?

Accepted articles are published online after receipt of the corrected proofs.

Reformat to Biodrugs using Livewrite Premium

Is a cover letter required?

A cover letter is used when unpublished material is included in the manuscript and when suggesting reviewers the corresponding author should include reviewer identity details in the submission letter.

Reformat to Biodrugs using Livewrite Premium

What are the publication costs?

Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR. Subscription publishing has no APC charges.

Reformat to Biodrugs using Livewrite Premium

Research Topics

Biosimilars and Bioanalytical Methods Monoclonal and Polyclonal Antibodies Research Rheumatoid Arthritis Research and Therapies CAR-T cell therapy research Immunotherapy and Immune Responses RNA Interference and Gene Delivery Inflammatory Bowel Disease Pharmaceutical Economics and Policy Systemic Lupus Erythematosus Research Virus-based gene therapy research Chronic Lymphocytic Leukemia Research Asthma and respiratory diseases Protein purification and stability HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers Renal Transplantation Outcomes and Treatments Health Systems, Economic Evaluations, Quality of Life Psoriasis: Treatment and Pathogenesis Spondyloarthritis Studies and Treatments Neutropenia and Cancer Infections Autoimmune and Inflammatory Disorders Research Immunodeficiency and Autoimmune Disorders Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Hepatitis B Virus Studies

Related Journals

BE
Biochimica Et Biophysica Acta-reviews On Cancer Elsevier BV
IJ
International Journal Of Antimicrobial Agents Elsevier BV
AJ
Asian Journal Of Pharmaceutical Sciences Elsevier BV
JO
Jnci-journal Of The National Cancer Institute Oxford University Press
CC
Cancer Cell CELL PRESS
NR
Nature Reviews Clinical Oncology NATURE PORTFOLIO